Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application: Chimeric Ebola and Marburg Virus Glycoproteins Virus Like Particle Vaccine to Protect Against Diverse Ebola and Marburg Viruses

Federal Register: April 21, 2010 (Volume 75, Number 76)

Notices

Page 20828

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr21ap10-43

DEPARTMENT OF DEFENSE

Department of the Army

Availability for Non-Exclusive, Exclusive, or Partially Exclusive

Licensing of U.S. Patent Application Concerning a Chimeric Ebola and

Marburg Virus Glycoproteins Virus Like Particle Vaccine To Protect

Against Diverse Ebola and Marburg Viruses

AGENCY: Department of the Army, DoD.

ACTION: Notice.

SUMMARY: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 61/338,967, entitled ``A Chimeric Ebola and Marburg Virus Glycoproteins Virus Like

Particle Vaccine To Protect Against Diverse Ebola and Marburg

Viruses.'' The United States Government, as represented by the

Secretary of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command,

ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick,

Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth

Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul

Mele, Office of Research and Technology Applications (ORTA), (301) 619- 6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to a chimeric Ebola and Marburg virus glycoproteins virus like particle vaccine and its use to protect against highly fatal diverse Ebola and Marburg viruses, in which no vaccine or proven countermeasure exists.

Brenda S. Bowen,

Army Federal Register Liaison Officer.

FR Doc. 2010-9150 Filed 4-20-10; 8:45 am

BILLING CODE 3710-08-P